ARTICLES
Lung cancer cure, care, and cost: let the data be your guide
MG Kris
JCO Sep 1 1997: 3027–3029. [PDF]
	Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group
	E Work, OS Nielsen, SM Bentzen, K Fode, and T Palshof
	JCO Sep 1 1997: 3030–3037. [Abstract] [PDF]
	Cost of combined modality interventions for stage III non-small-cell lung cancer
	WK Evans, BP Will, JM Berthelot, and CC Earle
	JCO Sep 1 1997: 3038–3048. [Abstract] [PDF]
	Lung cancer practice guidelines: lessons learned and issues addressed by the Ontario Lung Cancer Disease Site Group
	WK Evans, T Newman, I Graham, JJ Rusthoven, D Logan, FA Shepherd, and D Chamberlain
	JCO Sep 1 1997: 3049–3059. [Abstract] [PDF]
	Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease
	S Bodis, MD Kraus, G Pinkus, B Silver, ME Kadin, GP Canellos, LN Shulman, NJ Tarbell, and PM Mauch
	JCO Sep 1 1997: 3060–3066. [Abstract] [PDF]
	Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies
	RA Brown, D Adkins, LT Goodnough, JS Haug, G Todd, M Wehde, D Hendricks, C Ehlenbeck, L Laub, and J DiPersio
	JCO Sep 1 1997: 3067–3074. [Abstract] [PDF]
	Innovation in the management of soft tissue sarcomas in infants and young children: high-dose-rate brachytherapy
	S Nag, R Martinez-Monge, F Ruymann, A Jamil, and C Bauer
	JCO Sep 1 1997: 3075–3084. [Abstract] [PDF]
	AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee
	SE Krown, MA Testa, and J Huang
	JCO Sep 1 1997: 3085–3092. [Abstract] [PDF]
	Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial
	Sr Loehrer PJ, M Chen, K Kim, SC Aisner, LH Einhorn, R Livingston, and D Johnson
	JCO Sep 1 1997: 3093–3099. [Abstract] [PDF]
	Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results
	JR Clark, PM Busse, CM Norris, Jr, JW Andersen, AI Dreyfuss, RM Rossi, MD Poulin, AD Colevas, RB Tishler, R Costello, JW Lucarini, D Lucarini, L Thornhill, M Lackey, E Peters, and MR Posner
	JCO Sep 1 1997: 3100–3110. [Abstract] [PDF]
	p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma
	P Hirvikoski, E Kumpulainen, J Virtaniemi, R Johansson, H Haapasalo, S Marin, P Halonen, H Helin, H Raitiola, J Pukander, P Kellokumpu-Lehtinen, and VM Kosma
	JCO Sep 1 1997: 3111–3120. [Abstract] [PDF]
	Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium
	MR Fetell, SA Grossman, JD Fisher, B Erlanger, E Rowinsky, J Stockel, and S Piantadosi
	JCO Sep 1 1997: 3121–3128. [Abstract] [PDF]
	Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients
	K Lote, T Egeland, B Hager, B Stenwig, K Skullerud, J Berg-Johnsen, I Storm- Mathisen, and H Hirschberg
	JCO Sep 1 1997: 3129–3140. [Abstract] [PDF]
	Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group
	MJ Byrne, V Gebski, J Forbes, MH Tattersall, RJ Simes, AS Coates, J Dewar, M Lunn, C Flower, PG Gill, and J Stewart
	JCO Sep 1 1997: 3141–3148. [Abstract] [PDF]
	Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer
	MJ Piccart, J Klijn, R Paridaens, M Nooij, L Mauriac, R Coleman, M Bontenbal, A Awada, J Selleslags, A Van Vreckem, and M Van Glabbeke
	JCO Sep 1 1997: 3149–3155. [Abstract] [PDF]
	Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer
	GR Hudes, F Nathan, C Khater, N Haas, M Cornfield, B Giantonio, R Greenberg, L Gomella, S Litwin, E Ross, S Roethke, and C McAleer
	JCO Sep 1 1997: 3156–3163. [Abstract] [PDF]
Diagnosis in oncology. Hand-foot syndrome
A Jucgla and G Sais
JCO Sep 1 1997: 3164. [PDF]
Postchemotherapy surgery in nonseminoma
EW Steyerberg, HJ Keizer, and DT Sleijfer
JCO Sep 1 1997: 3165–3166. [PDF]
Is minimal residual disease in the peripheral-blood stem-cell transplantation of chronic myelogenous leukemia important?
EC Besa
JCO Sep 1 1997: 3166–3167. [PDF]
Coumarin-induced hepatotoxicity
CL Loprinzi, J Sloan, and J Kugler
JCO Sep 1 1997: 3167–3168. [PDF]

SPECIAL DEPARTMENTS
Erratum
	EMA/CO for High-Risk Gestational Trophoblastic Tumors: Results From a Cohort of 272 Patients
	M. Bower, E.S. Newlands, L. Holden, D. Short, C. Brock, G.J.S. Rustin, R.H.J. Begent, and K.D. Bagshawe
	JCO Sep 1 1997: 3168. [Abstract] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.